CCA
TWST icon

Cadent Capital Advisors’s Twist Bioscience TWST Stock Holding History

Cadent Capital Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,665
Closed -$622K – 145
2021
Q2 		$622K Buy
+4,665
New +$542K 0.26% 60

Other funds holding TWST

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Cadent Capital Advisors's TWST Position: Q3 2021 in Review

Cadent Capital Advisors sold out of Twist Bioscience (TWST) in Q3 2021, closing a stake of 4,665 shares — an estimated $622K sold.

Cadent Capital Advisors first reported a position in TWST in Q2 2021 and held it in 1 quarter. The position peaked at $622K in Q2 2021. 235 funds tracked by Wall St. Rank hold TWST as of Q3 2021.

  • Cadent Capital Advisors reported no remaining Twist Bioscience position as of Q3 2021 after selling out during the quarter.
  • Cadent Capital Advisors sold 4,665 Twist Bioscience shares in Q3 2021, an estimated $622K.
  • Cadent Capital Advisors first reported a position in Twist Bioscience in Q2 2021 and held it in 1 quarter.
  • Cadent Capital Advisors's Twist Bioscience position peaked at $622K in Q2 2021.
  • 235 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2021.

Based on Cadent Capital Advisors's 13F filing for Q3 2021, filed 25 Oct 2021.